Lyell Immunopharma (NASDAQ:LYEL) Receives Nasdaq Notification Regarding Minimum Bid Price Requirements
Lyell Immunopharma, Inc. (NASDAQ: LYEL) recently disclosed in a Form 8-K filing with the Securities and Exchange Commission that it has received a notice from the Listing Qualifications Staff of The Nasdaq Stock Market LLC. The notice, received on January 23, 2025, informed the company that for the past 33 consecutive business days, the bid […]
More Stories
US Consumers Grow More Optimistic About Future Finances, Recession Fears Retreat
By Tom Ozimek U.S. consumers grew more hopeful about their future financial prospects in December and edged away from worst-case...
ICE Arrests 101 Illegal Alien Truckers in California
By Naveen Athrappully Authorities have arrested 101 illegal immigrant truck drivers from California highways under Operation Highway Sentinel, Immigration and...
Florence Pugh: Net Worth, Salary, and Relationship with Finn Cole
British movies, blockbusters, and even Marvel movies have enabled Florence Pugh to have a strong career in Hollywood. She is...
Macron Affirms Support for Greenland Sovereignty Amid US Interest in Annexation
By Rachel Roberts French President Emmanuel Macron has reaffirmed his support for the sovereignty of the Danish territory of Greenland...
DOJ Releases More Epstein Files, Says Some Documents Contain False Claims
By Jack Phillips The Department of Justice (DOJ) on Tuesday morning released thousands of documents related to the now-deceased convicted...
House Oversight Committee Expands Investigation Into Minnesota Fraud
By Jackson Richman The House Oversight Committee expanded its investigation into fraud in Minnesota on Dec. 22. The committee has...